Hal C Jones

Title: Hal C Jones: Innovator in Anti-Infective Research

Introduction

Hal C Jones is a notable inventor based in Corvallis, Oregon. He has made significant contributions to the field of anti-infective research, particularly through his innovative work on proteases. His research focuses on the DegP periplasmic protease, which plays a crucial role in the virulence of Gram-negative pathogens.

Latest Patents

Hal C Jones holds a patent for his invention titled "DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function." This patent describes an assay for inhibitors of DegP activity, which involves mixing a suspected inhibitor with DegP and a suitable substrate, such as the native substrate PapA. The invention aims to detect changes in DegP activity, which is essential for the removal of misfolded proteins in the periplasm. The findings from this patent have the potential to lead to the design of small molecule inhibitors that can target protease function effectively.

Career Highlights

Throughout his career, Hal C Jones has focused on understanding the mechanisms of proteases and their role in bacterial virulence. His work has contributed to the identification of native substrates for DegP and the development of assays that can be used to screen for potential inhibitors. His research is vital for advancing the field of anti-infective therapies.

Collaborations

Hal C Jones has collaborated with notable researchers, including Dennis E Hruby and Scott J Hultgren. These collaborations have enhanced the depth and impact of his research, allowing for a broader exploration of protease functions and their implications in infectious diseases.

Conclusion

Hal C Jones is a prominent inventor whose work on the DegP protease has opened new avenues for anti-infective research. His innovative approaches and collaborations continue to contribute to the understanding of bacterial virulence and the development of potential therapeutic targets.